| Accession Number | 0001955217-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 20, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Clinical Solutions | Common Stock | โ | Feb 18, 2026 | Tax Withholding | 252 | $210.01 | $52,922.52 | 8,173 | Direct | โ | View Details | |
SVP, Clinical Solutions | Common Stock | โ | Feb 18, 2026 | Tax Withholding | 259 | $206.99 | $53,610.41 | 7,914 | Direct | โ | View Details | |
SVP, Clinical Solutions | Common Stock | โ | Feb 18, 2026 | Grant/Award | 2,135 | $0.00 | $0.00 | 10,049 | Direct | โ | View Details | |
SVP, Clinical Solutions | Common Stock | โ | Jan 28, 2026 | Small Acquisition | 16 | $183.52 | $2,936.26 | 10,065 | Direct | โ | View Details | |
SVP, Clinical Solutions | Non-Qualifed Stock Option (right to buy) | Derivative | Feb 18, 2026 | Grant/Award | 9,853 | $0.00 | $0.00 | 9,853 | Direct | โ | View Details |